Molecular targeting for treatment of human T-lymphotropic virus type 1 infection-Reference-Cited by-同舟云学术

Molecular targeting for treatment of human T-lymphotropic virus type 1 infection

Published:2019-01 Issue: Volume:109 Page:770-778
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Soltani Arash^ORCID,Hashemy Seyed Isaac^ORCID,Zahedi Avval Farnaz,Soleimani Anvar,Rafatpanah Houshang,Rezaee Seyed Abdorahim,Griffith Renate,Mashkani Baratali^ORCID

Funder

Mashhad University of Medical Sciences

National Institute for Medical Research Development

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference135 articles.

1. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma;Poiesz;Proc. Natl. Acad. Sci. U. S. A.,1980

2. Reducing the global burden of HTLV-1 infection: an agenda for research and action;Willems;Antivir. Res.,2017

3. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells;Jones;Nat. Med.,2008

4. HTLV-1, immune response and autoimmunity;Quaresma;Viruses,2016

5. Pathways of cell-cell transmission of HTLV-1;Pique;Front. Microbiol.,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into human T‐lymphotropic virus type‐1 (HTLV‐1) pathogenesis‐host interactions in the manifestation of HTLV‐1‐associated myelopathy/tropical spastic paraparesis;Reviews in Medical Virology;2024-06-27

2. Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention;Pharmaceuticals;2024-06-05

3. Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease;The Lancet Microbe;2024-04

4. HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors;Virology Journal;2024-01-10

5. Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy;Expert Review of Neurotherapeutics;2023-11-07